Skip to content

Developing Interventions for Protecting HIV-Exposed Uninfected Infants Against Severe Infections

Developing Interventions for Protecting HIV-Exposed Uninfected Infants Against Severe Infections

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07052409
Enrollment
72
Registered
2025-07-04
Start date
2025-04-10
Completion date
2029-07-01
Last updated
2026-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gut Microbiome

Keywords

Gut microbiome, HIV-exposed uninfected infant

Brief summary

Research has shown that babies who are exposed to HIV, but are uninfected (negative HIV status), have a bigger risk of developing severe infections. There are naturally occurring organisms in the gut that may determine how the body protects itself against infections. These organisms may be different in babies who were exposed to the HIV virus in utero, compared to those who were not exposed. This study wants to see if the organisms in the gut of babies can be modified by supplementing the diet of the pregnant mother or of the baby at 6 months of age with Inkomasi (pasteurized fermented milk). The study will compare the type and amount of organisms in those who received supplementation and those who did not receive supplementation.

Detailed description

1. The study will enroll 24 pregnant women with HIV at 36 weeks gestational age and randomize them 1:1 to receive 500 ml daily of pasteurized fermented milk (Inkomasi) or not. Changes in maternal gut microbiota from enrollment to 2-4 weeks postpartum will be compared between groups. The study will also compare the gut microbiome at infants born to mothers who received Inkomasi with those born to mothers who did not receive Inkomasi. 2. The study will enroll 24 HIV-exposed uninfected infants (HEU) at 24 weeks of age and randomize them 1:1 to receive ≥15 ml daily of pasteurized fermented milk (Inkomasi) or not. Changes in infant gut microbiota from enrollment to 4 weeks after enrollment will be compared between groups.

Interventions

DIETARY_SUPPLEMENTInkomazi

Pasteurized fermented milk

Sponsors

University of Colorado, Denver
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Months to 45 Years
Healthy volunteers
No

Inclusion criteria

* Pregnant women with HIV HIV-exposed uninfected infants

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Infant gut microbiomefrom enrollment to 4-10 weeks after enrollment16s rRNA and metagenomic sequencing
Maternal gut microbiome4-10 weeks after initiation of the interventionShotgun metagenomics and 16s rRNA

Countries

South Africa

Contacts

PRINCIPAL_INVESTIGATORAdriana Weinberg, MD

AMC UCD

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 16, 2026